Search

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Cancer Drug Discovery is an international, peer-reviewed journal on all aspects of anti-cancer drug discovery, published bimonthly (print & online) by Bentham Science Publishers.

Current Cancer Drug Targets aims to cover all the latest and outstanding developments in full spectrum of cancer drug discovery and development, including but not limited to cellular and molecular biology, genomics, proteomics, metabolomics, medicinal chemistry, pharmacology, toxicology, and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters/commentary/perspectives, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel drug targets for human anticancer drug discovery continues to grow, this journal has become essential reading for all biomedical and pharmaceutical scientists involved in drug discovery and development. Its scope covers publications related to prevention, diagnosis and treatment of all types of human cancers in various of basic and translational researches, including cancer etiology, signal transduction, biomarker, chemotherapy, hormone therapy, gene therapy, immunotherapy, radiotherapy, immunotherapy and combination therapy, stem cell, tumor environment, metabolism emphasizing on advanced mechanistic investigations.

Current Cancer Drug Targets is an international, peer-reviewed journal on all aspects of cancer drug discovery and development, published monthly (print & online) by Bentham Science Publishers.

Current Medicinal Chemistry covers all the latest and outstanding developments in the field of medicinal chemistry. It also includes topics related to quantitative structure-function relationships, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization, and organic syntheses of naturally occurring compounds, as well as chemical and analytical techniques used in rational drug design. Each issue incorporates a series of timely, in-depth/mini-reviews and guest-edited thematic issues written by leaders in the field, covering a range of  current topics in medicinal chemistry. The journal also publishes reviews on recent patents.

Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be informed and remain up-to-date with the latest and most important developments relevant to their field.

Current Medicinal Chemistry is an international, peer-reviewed journal on all aspects of medicinal chemistry, published weekly (print & online) by Bentham Science Publishers.

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.

Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.

Current Gene Therapy is an international, peer-reviewed journal on all aspects of gene and cell therapy, published bi-monthly (print & online) by Bentham Science Publishers.

The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Mini-Reviews in Medicinal Chemistry covers all areas of medicinal chemistry, including quantitative structure-function relationships, synthetic chemistry, bioorganic chemistry, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug safety profile and drug-induced liver injury (DILI), drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization and organic syntheses of naturally occurring compounds, "nanosystem and nanocarriers", as well as chemical and analytical techniques used in rational drug design.

Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to remain  informed and up-to-date with the latest and most important developments.

Mini-Reviews in Medicinal Chemistry is an international, peer-reviewed journal on all aspects of medicinal chemistry, published bi-weekly (print & online) by Bentham Science Publishers.

Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to in-depth mini-reviews/ research and guest-edited reviews/ research which provide the reader with a comprehensive survey of that respective area. A Guest Editor who is an expert in the topic under review will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. Understanding the relationship between structure and function is crucial to understand the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be informed and up-to-date with the latest and most important advances.

Current Topics in Medicinal Chemistry is an international, peer-reviewed journal on all aspects of medicinal chemistry, published weekly (print & online) by Bentham Science Publishers.

Recent Patents on Nanotechnology publishes full-length/mini-reviews and research articles that reflect or deal with studies related to patents, the application of reported patents in a study, discussion of the comparison of results regarding the application of a given patent, and also guest-edited thematic issues on recent patents in the field of nanotechnology. A selection of important and recent patents on nanotechnology is also included in the journal. The journal is essential reading for all researchers involved in nanotechnology. The scope of the journal covers the following areas, including, but not limited to:

●     Advanced Nanomaterials
●     Nanobiotechnology and Nanomedicine
●     Nanoelectronics and Nanophotonics
●     Nanomechanics, Computational Nanoscience, and Technology
●     Nanometrology, Instrumentation, and Measurement
●     Nanosystems, Nanorobotics, Nanosensors, and Nanoactuators
●     Nanotechnology for Energy
●     Other related areas

Recent Patent on Nanotechnology is an international, peer-reviewed journal on all aspects of nanotechnology, published quarterly (print & online) by Bentham Science Publishers. 

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents. Each issue contains a series of timely in-depth/mini-reviews and guest-edited issues written by leaders in the field covering a range of current topics in oncology and medicinal chemistry. The journal considers high-quality reviews and research papers for publication. Scientific areas within the scope of the journal include:

●     Medicinal chemistry, prevention, diagnosis, and treatment of malignant diseases
●     In silico studies of drug-target interaction in anti-cancer drug assessment
●     Underlying biology and medicinal chemistry strategies for anti-cancer drug synthesis and development
●     New drugs related to a specific target or target class for anticancer drugs
●     Drug repositioning in cancer
●     Clinical cancer research
●     Radiotherapy and systemic treatment of cancer
●     Other related areas

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.

Anti-Cancer Agents in Medicinal Chemistry is an international, peer-reviewed journal on all aspects of the discovery of anti-cancer agents in medicinal chemistry, published bi-weekly (print & online) by Bentham Science Publishers.

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders, e.g., disease-specific proteins, receptors, enzymes, and genes.

CNS & Neurological Disorders - Drug Targets publishes guest-edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts original research articles, letters, reviews, and drug clinical trial studies for publication.

As the discovery, identification, characterization, and validation of novel human drug targets for neurological and CNS drug discovery continue to grow, this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets is an international, peer-reviewed journal on all aspects of neurological disorders, published monthly (print & online) by Bentham Science Publishers.

Current Drug Delivery aims to publish peer-reviewed articles, research articles, in-depth reviews/mini-reviews, and drug clinical trial studies in the rapidly developing field of drug delivery. Modern drug research aims to build the delivery properties of a drug at the design phase; however, in many cases, this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.